Results 131 to 140 of about 10,653,637 (311)

Prioritising health information needs in Europe: a Policy Delphi survey [PDF]

, 2020
Stefanie Seeling, Martin Thißen, Peter Achterberg, Flavia Carle, Ronan A Lyons, Herman Van Oyen, Mariken Tijhuis, Brigid Unim, Ausra Zelviene, Angela Fehr   +9 more
openalex   +1 more source

In situ molecular organization and heterogeneity of the Legionella Dot/Icm T4SS

FEBS Letters, EarlyView.
We present a nearly complete in situ model of the Legionella Dot/Icm type IV secretion system, revealing its central secretion channel and identifying new components. Using cryo‐electron tomography with AI‐based modeling, our work highlights the structure, variability, and mechanism of this complex nanomachine, advancing understanding of bacterial ...
Przemysław Dutka, Yuxi Liu, Stefano Maggi, Debnath Ghosal, Jue Wang, Prashant P. Damke, Stephen D. Carter, Wei Zhao, Sukhithasri Vijayrajratnam, Joseph P. Vogel, Carrie L. Shaffer, Grant J. Jensen   +11 more
wiley   +1 more source

Attacking the Obesity Epidemic: The Potential Health Benefits of Providing Nutrition Information in Restaurants

, 2006
Scot Burton, Elizabeth H. Creyer, Jeremy Kees, Kyle A. Huggins   +3 more
openalex   +1 more source

A National Dialogue on Health Information Technology and Privacy [PDF]

, 2009
Increasingly, government leaders recognize that solving the complex problems facing America today will require more than simply keeping citizens informed.
Alan P. Balutis, C. Alan Lyles, Franklin S. Reeder, Gary A. Christopherson, Sallyanne Payton   +4 more
core  

Cell wall target fragment discovery using a low‐cost, minimal fragment library

FEBS Letters, EarlyView.
LoCoFrag100 is a fragment library made up of 100 different compounds. Similarity between the fragments is minimized and 10 different fragments are mixed into a single cocktail, which is soaked to protein crystals. These crystals are analysed by X‐ray crystallography, revealing the binding modes of the bound fragment ligands.
Kaizhou Yan, Mathew Stanley, Olawale Raimi, Andrew T. Ferenbach, Helge C Dorfmueller, Daan M. F. van Aalten   +5 more
wiley   +1 more source

Healthy from the Start: Co‐Designing Sleep, Nutrition and Physical Activity Resources for Young Shiftworkers—Novel Implementation and Evaluation

Health Expectations
Introduction The increasing prevalence of shiftwork among young adults poses significant health risks, primarily due to its disruptive effects on sleep, nutrition and physical activity.
Alexandra E. Shriane, Sally A. Ferguson, Gabrielle Rigney, Charlotte C. Gupta, Tracy Kolbe‐Alexander, Madeline Sprajcer, Cassie Hilditch, Robert Stanton, Matthew J. W. Thomas, Jessica L. Paterson, Jamie Marino, Grace E. Vincent   +11 more
doaj   +1 more source

Getting the Right Mix: Developing a primary - secondary health provider IT interface in the Waikato District Health Board [PDF]

, 2007
The article presents a study on the electronic health record systems (EHR) developed by Waikato District Health Board (DHB) in New Zealand. The DHB develop EHR with the intention of integrating primary, secondary and tertiary provider information.
Gibb, Jenny L., Haar, Jarrod M.
core   +1 more source

Nicotinamide N‐methyltransferase promotes drug resistance in lung cancer, as revealed by nascent proteomic profiling

Molecular Oncology, EarlyView.
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou, Zhen Wang, Fei Yang, Xiao Han, Lei Li, Huadong Liu   +5 more
wiley   +1 more source

Readability and Suitability of Information Presented on a University Health Center Website.

, 2022
Alice Noblin, Richard I. Zraick, Ann Neville Miller, Mary Schmidt-Owens, Michael Deichen, Kelly Tran, Raj Patel   +6 more
openalex   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source